NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”) (NASDAQ:MRX), the diversified global financial services platform, today announces the pricing of the public offering (the “Offering”) of 10,283,802 ordinary shares by certain selling shareholders (the “Selling Shareholders”) at $35.50 per share. In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,542,570 ordinary shares.
Marex is not selling any ordinary shares in the Offering and will not receive any proceeds from any sale of shares by the Selling Shareholders. The Offering is expected to close on April 17, 2025, subject to customary closing conditions.
Goldman Sachs & Co. LLC, Barclays and Jefferies are acting as lead book-running managers and as representatives of the underwriters for the Offering. UBS Investment Bank, Keefe, Bruyette & Woods, a Stifel Company, Piper Sandler & Co., TD Securities and Berenberg are acting as bookrunners for the Offering.
The Offering is being made only by means of a prospectus. Copies of the prospectus relating to the Offering may be obtained from:
- Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: [email protected];
- Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at [email protected]; or
- Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388, or by email at [email protected].
A registration statement on Form F-1 relating to the Offering has been filed with, and was declared effective by, the U.S. Securities and Exchange Commission (the “SEC”). This press …
Full story available on Benzinga.com
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”) (NASDAQ:MRX), the diversified global financial services platform, today announces the pricing of the public offering (the “Offering”) of 10,283,802 ordinary shares by certain selling shareholders (the “Selling Shareholders”) at $35.50 per share. In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,542,570 ordinary shares.
Marex is not selling any ordinary shares in the Offering and will not receive any proceeds from any sale of shares by the Selling Shareholders. The Offering is expected to close on April 17, 2025, subject to customary closing conditions.
Goldman Sachs & Co. LLC, Barclays and Jefferies are acting as lead book-running managers and as representatives of the underwriters for the Offering. UBS Investment Bank, Keefe, Bruyette & Woods, a Stifel Company, Piper Sandler & Co., TD Securities and Berenberg are acting as bookrunners for the Offering.
The Offering is being made only by means of a prospectus. Copies of the prospectus relating to the Offering may be obtained from:
- Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: [email protected];
- Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at [email protected]; or
- Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388, or by email at [email protected].
A registration statement on Form F-1 relating to the Offering has been filed with, and was declared effective by, the U.S. Securities and Exchange Commission (the “SEC”). This press …
Full story available on Benzinga.com
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”) (NASDAQ:MRX), the diversified global financial services platform, today announces the pricing of the public offering (the “Offering”) of 10,283,802 ordinary shares by certain selling shareholders (the “Selling Shareholders”) at $35.50 per share. In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,542,570 ordinary shares.
Marex is not selling any ordinary shares in the Offering and will not receive any proceeds from any sale of shares by the Selling Shareholders. The Offering is expected to close on April 17, 2025, subject to customary closing conditions.
Goldman Sachs & Co. LLC, Barclays and Jefferies are acting as lead book-running managers and as representatives of the underwriters for the Offering. UBS Investment Bank, Keefe, Bruyette & Woods, a Stifel Company, Piper Sandler & Co., TD Securities and Berenberg are acting as bookrunners for the Offering.
The Offering is being made only by means of a prospectus. Copies of the prospectus relating to the Offering may be obtained from:
Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: [email protected];
Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at [email protected]; or
Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388, or by email at [email protected].
A registration statement on Form F-1 relating to the Offering has been filed with, and was declared effective by, the U.S. Securities and Exchange Commission (the “SEC”). This press …Full story available on Benzinga.com Read MoreMRX, News, IPOs, Press Releases, General IPOs
